Oppenheimer & CO Inc Adamis Pharmaceuticals Corp Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$0.52 - $1.45 $2,080 - $5,800
-4,000 Reduced 25.0%
12,000 $9,000
Q2 2019

Aug 09, 2019
SELL
$1.26 - $2.23 $1,260 - $2,230
-1,000 Reduced 5.88%
16,000 $21,000
Q4 2018

Jan 29, 2019
BUY
$2.1 - $3.21 $35,700 - $54,570
17,000 New
17,000 $38,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email